C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/17/2002	US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass
10/17/2002	US20020150576 Humanized anti-CCR2 antibodies and methods of use therefor
10/17/2002	US20020150569 Using monoclonal antibodies
10/17/2002	US20020150567 Novel grb2 associating polypeptides and nucleic acids encoding therefor
10/17/2002	US20020150566 Administering hybrid Ras proteins; anticancer agents
10/17/2002	US20020150563 Hybrid polynucleotide; antibodies
10/17/2002	US20020150559 Binding of human antigens
10/17/2002	US20020150558 Immobilization; viricides
10/17/2002	US20020150555 Interleukins; osteoporosis therapy
10/17/2002	US20020150554 Chicken interleukin-15 and uses thereof
10/17/2002	US20020150552 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
10/17/2002	US20020150551 Protease surface treatment
10/17/2002	US20020150541 Mixture of human interferons; viricides; anticancer agents; antiinflammatory agents;
10/17/2002	US20020150534 Tumor necrosis factor-gamma
10/17/2002	DE10162387A1 Für das rpoB-Gen kodierende Nukleotidsequenzen For the rpoB gene coding nucleotide sequences
10/17/2002	DE10116788A1 Nichtpathogener bakterieller Poringen-Rezipientenstamm eines Mycolsäure-haltigen Bakteriums, Verfahren zu dessen Herstellung und dessen Verwendung Nonpathogenic bacterial porin-recipient strain of mycolic acid-containing bacteria, a process for its preparation and its use
10/17/2002	DE10116518A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A process for the fermentative preparation of L-amino acids using strains of the family Enterobacteriaceae
10/17/2002	DE10107843A1 Identifying herbicides and plant growth regulators, from ability to inhibit specific genes, also use of these genes to prepare herbicide-resistant transgenic plants
10/17/2002	CA2827167A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2606839A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2446886A1 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002	CA2443666A1 Suppression of androgen receptor transactivation through new pathways to ar and ar coactivators and repressors
10/17/2002	CA2443654A1 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
10/17/2002	CA2443405A1 Use of cd25 binding molecules in steroid-resistant patients
10/17/2002	CA2443341A1 Human gene critical to fertility
10/17/2002	CA2443334A1 Protein modification and maintenance molecules
10/17/2002	CA2443332A1 .alpha..nu..beta.3 integrin-binding polypeptide monobodies and their use
10/17/2002	CA2443330A1 Anti-osteopontin antibody and use thereof
10/17/2002	CA2443323A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	CA2443293A1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	CA2443277A1 Interferon gamma polypeptide variants
10/17/2002	CA2443264A1 Gene encoding plant protein tm2a, conferring resistance to tomato mosaic virus
10/17/2002	CA2443223A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	CA2443166A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/17/2002	CA2443085A1 Somatostatin agonists
10/17/2002	CA2443067A1 Protein analysis by means of immobilized arrays of antigens or antibodies
10/17/2002	CA2442915A1 Compositions and method for enhancing proteoglycan production
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2442651A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/17/2002	CA2442574A1 Novel proteins and nucleic acids encoding same
10/17/2002	CA2442386A1 Epitope sequences
10/17/2002	CA2441633A1 Fragment of l. lactis plasmid conferring antiphage activity and uses thereof
10/17/2002	CA2441626A1 Fusion protein construct and method for inducing hiv-specific serum igg and secretory iga antibodies in-vivo
10/17/2002	CA2441538A1 Stimulation of osteogenesis using rank ligand fusion proteins
10/17/2002	CA2440219A1 Proteins, polynucleotides encoding them and methods of using the same
10/17/2002	CA2440196A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
10/17/2002	CA2439503A1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
10/17/2002	CA2439342A1 Oryza sativa nuclear cap binding protein 80
10/17/2002	CA2437073A1 Novel nucleic acids and polypeptides
10/17/2002	CA2436805A1 Cell cycle nucleic acids, polypeptides and uses thereof
10/17/2002	CA2436278A1 Method for the detection of cytochrome b mutations in fungi
10/17/2002	CA2435528A1 Novel polypeptides and nucleic acids encoded thereby
10/17/2002	CA2434456A1 Yeast genes that affect viral replication
10/16/2002	EP1249498A2 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
10/16/2002	EP1249492A2 Antibodies against an adrenergic receptor
10/16/2002	EP1249491A2 Human very long chain acyl-CoA synthase (VLCAS)-like protein and nucleic acids encoding it
10/16/2002	EP1249490A2 In vitro activation of cytotoxic T cells
10/16/2002	EP1249160A1 Model animal with favorite onset of rheumatoid arthritis
10/16/2002	EP1248849A1 Obg3 globular head and uses thereof for decreasing body mass
10/16/2002	EP1248848A1 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
10/16/2002	EP1248845A1 Specific fruit- plant promoter
10/16/2002	EP1248844A1 Analogs of human basic fibroblast growth factor
10/16/2002	EP1248843A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
10/16/2002	EP1248842A1 2871 receptor, a g-protein coupled receptor and methods of use thereof
10/16/2002	EP1248841A2 Genes differentially expressed in breast cancer
10/16/2002	EP1248839A2 Tumor and senescence marker
10/16/2002	EP1248803A2 Nogo receptor-mediated blockade of axonal growth
10/16/2002	EP1248802A2 Soluble ctla4 mutant molecules and uses thereof
10/16/2002	EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002	EP1248800A2 Compositions and methods for therapy and diagnosis of breast cancer
10/16/2002	EP1248799A2 Chemically modified hiv envelope glycoprotein
10/16/2002	EP1248798A2 Human dna sequences
10/16/2002	EP1248797A1 Process for the purification of antithrombin-iii
10/16/2002	EP1248796A1 Process for the purification of antothrombin-iii
10/16/2002	EP1248648A2 Vaccination against canine herpesvirus infection and vaccines
10/16/2002	EP1248645A1 Novel chimeric proteins and methods for using the same
10/16/2002	EP1248642A1 Vegf-d/vegf-c/vegf peptidomimetic inhibitor
10/16/2002	EP1248552A1 Pp14 fusion proteins and methods for making and using the same
10/16/2002	EP1248518A2 Transgenic mouse model of human neurodegenerative disease
10/16/2002	EP1248516A2 38 human secreted proteins
10/16/2002	EP1190123B1 Encapsulation of crystals via multilayer coatings
10/16/2002	EP1017785A4 Rna export element and methods of use
10/16/2002	EP0977836A4 Leafy cotyledon1 genes and their uses
10/16/2002	EP0973794B1 Netrin receptors
10/16/2002	EP0868429B1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/16/2002	EP0774001B1 Production of tissue factor pathway inhibitor
10/16/2002	EP0750669B1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM
10/16/2002	EP0746622B1 Antifungal proteins, dna coding therefor, and hosts incorporating same
10/16/2002	EP0672128B1 Stem cell proliferation factor
10/16/2002	EP0670847B1 Subtilin variant of enhanced stability and activity
10/16/2002	EP0639225B1 New polypeptides and peptides, nucleic acids coding for them, and their use in the field of tumor therapy, inflammation or immunology
10/16/2002	EP0619742B1 Transfection of lung via aerosolized transgene delivery
10/16/2002	EP0523187B1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
10/16/2002	CN1375011A Nucleic acid comprising the sequence of a promoter inductible by stress and a gene sequence coding for a stilbene synthase
10/16/2002	CN1375010A Targeted gene removal
10/16/2002	CN1375009A Insect-resistant rice plants
10/16/2002	CN1375007A A gene encoding a novel threonyl-tRNA synthetase, its uses and the preparing methods
10/16/2002	CN1375006A Novel compound

1 ... 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 1757 1758 1759 ... 2916